Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2026-01-26 @ 9:45 PM
Study NCT ID:
NCT04681118
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-04-23
First Post:
2020-12-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS
Sponsor:
Brainstorm-Cell Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BCT-003-US
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None